Daniela Gattini Valdes
Biography
Dr. Daniela Gattini joined the Division of Gastroenterology, Hepatology & Nutrition as a Staff Physician in 2022. She is an Assistant Professor at the University of Toronto.
Dr. Gattini graduated in medicine from the Catholic University of Chile and trained in paediatric gastroenterology in the Catholic University of Chile and The Hospital for Sick Children (SickKids) in Toronto. She completed a Fellowship in Intestinal Failure and a Fellowship in Hepatology and Liver Transplantation at SickKids.
Dr. Gattini is currently completing a PhD in Clinical Epidemiology at the Institute of Health Policy, Management and Evaluation at the University of Toronto.
Research
Dr. Gattini's main clinical and research interest is within the fields of Intestinal Failure and Intestine and Liver Transplantation. Her current work focuses on the outcomes and health-related quality of life of children with intestinal failure and their caregivers. She is also working on the development of health utilities in paediatric intestinal failure and conducting relevant health economic evaluations in the field.
Publications
- Gattini D, Murphy A, Belza C, Avitzur Y, Wales PW. Are enteral devices risk factors for central line-associated bloodstream infections in children with intestinal failure? Clin Nutr. 2025 Feb;45:75-80.
- Sandy NS, Roberts AJ, Wales PW, Toma RK, Belza C, Dogra H, Evans HM, Gattini D, Hind J, Mercer D, Povondra JM, Turner J, Yap J, Wong T, Avitzur Y. Small and large bowel anatomy is associated with enteral autonomy in infants with short bowel syndrome: A retrospective cohort study. JPEN J Parenter Enteral Nutr. 2024 Feb;48(2):231-238.
- Gattini D, Belza C, Kraus R, Avitzur Y, Ungar WJ, Wales PW. Cost-utility analysis of teduglutide compared to standard care in weaning parenteral nutrition support in children with short bowel syndrome. Clin Nutr. 2023 Dec;42(12):2363-2371.
- Gattini D, Yan H, Belza C, Avitzur Y, Wales PW. Cost-utility analysis of 4% tetrasodium ethylenediaminetetraacetic acid, taurolidine, and heparin lock to prevent central line-associated bloodstream infections in children with intestinal failure. JPEN J Parenter Enteral Nutr. 2024 Jan;48(1):47-56.
- Gattini D, Roberts AJ, Wales PW, Beath SV, Evans HM, Hind J, Mercer D, Wong T, Yap J, Belza C, Huysentruyt K, Avitzur Y. Trends in Pediatric Intestinal Failure: A Multicenter, Multinational Study. J Pediatr. 2021 Jun 18:S0022-3476(21)00555-2. doi: 10.1016/j.jpeds.2021.06.025.

